

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.36623180 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.59717923 |
| 3 | myofibril assembly (GO:0030239) | 7.92465658 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.57267943 |
| 5 | muscle filament sliding (GO:0030049) | 7.37533154 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.37533154 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.88624293 |
| 8 | response to muscle activity (GO:0014850) | 6.79120365 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.76890103 |
| 10 | cardiac muscle contraction (GO:0060048) | 6.76238634 |
| 11 | plasma membrane repair (GO:0001778) | 6.47494264 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 6.41235394 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.35636018 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.28689647 |
| 15 | cardiac muscle cell development (GO:0055013) | 6.25548829 |
| 16 | regulation of skeletal muscle contraction (GO:0014819) | 6.17498277 |
| 17 | actin-mediated cell contraction (GO:0070252) | 6.06862473 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 6.06554724 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 6.02230592 |
| 20 | cardiac cell development (GO:0055006) | 5.86846085 |
| 21 | actomyosin structure organization (GO:0031032) | 5.86235459 |
| 22 | adult heart development (GO:0007512) | 5.79799837 |
| 23 | skeletal muscle fiber development (GO:0048741) | 5.78377807 |
| 24 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.68358818 |
| 25 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.57132572 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.55574826 |
| 27 | striated muscle contraction (GO:0006941) | 5.48807168 |
| 28 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.47895248 |
| 29 | heart contraction (GO:0060047) | 5.47742712 |
| 30 | heart process (GO:0003015) | 5.47742712 |
| 31 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.46732078 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.41982989 |
| 33 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.39762129 |
| 34 | cardiac muscle hypertrophy (GO:0003300) | 5.30962402 |
| 35 | skeletal muscle adaptation (GO:0043501) | 5.30817308 |
| 36 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.27750946 |
| 37 | myotube cell development (GO:0014904) | 5.17039713 |
| 38 | regulation of sarcomere organization (GO:0060297) | 5.16272422 |
| 39 | heart trabecula formation (GO:0060347) | 5.12877432 |
| 40 | muscle tissue morphogenesis (GO:0060415) | 5.11986855 |
| 41 | regulation of cell communication by electrical coupling (GO:0010649) | 5.10549599 |
| 42 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.07234931 |
| 43 | striated muscle hypertrophy (GO:0014897) | 5.05693427 |
| 44 | carnitine shuttle (GO:0006853) | 5.01217791 |
| 45 | regulation of striated muscle contraction (GO:0006942) | 4.94712306 |
| 46 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.94076531 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.87471928 |
| 48 | glycogen catabolic process (GO:0005980) | 4.85917926 |
| 49 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.80843028 |
| 50 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.67855206 |
| 51 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.64805699 |
| 52 | ATP synthesis coupled proton transport (GO:0015986) | 4.64805699 |
| 53 | regulation of the force of heart contraction (GO:0002026) | 4.63524486 |
| 54 | muscle fiber development (GO:0048747) | 4.58740755 |
| 55 | respiratory electron transport chain (GO:0022904) | 4.56871092 |
| 56 | glucan catabolic process (GO:0009251) | 4.56622801 |
| 57 | actin filament-based movement (GO:0030048) | 4.53587510 |
| 58 | regulation of membrane repolarization (GO:0060306) | 4.51546845 |
| 59 | muscle hypertrophy (GO:0014896) | 4.47324040 |
| 60 | glucan biosynthetic process (GO:0009250) | 4.46570651 |
| 61 | glycogen biosynthetic process (GO:0005978) | 4.46570651 |
| 62 | electron transport chain (GO:0022900) | 4.43423927 |
| 63 | regulation of cofactor metabolic process (GO:0051193) | 4.36988821 |
| 64 | regulation of coenzyme metabolic process (GO:0051196) | 4.36988821 |
| 65 | skeletal muscle tissue development (GO:0007519) | 4.34615282 |
| 66 | creatine metabolic process (GO:0006600) | 4.31548209 |
| 67 | cell communication involved in cardiac conduction (GO:0086065) | 4.29210623 |
| 68 | muscle cell cellular homeostasis (GO:0046716) | 4.28389786 |
| 69 | cellular polysaccharide catabolic process (GO:0044247) | 4.27742635 |
| 70 | fatty acid transmembrane transport (GO:1902001) | 4.27091264 |
| 71 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.23040949 |
| 72 | positive regulation of myotube differentiation (GO:0010831) | 4.20725708 |
| 73 | NADH metabolic process (GO:0006734) | 4.19465506 |
| 74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.11097511 |
| 75 | skeletal muscle tissue regeneration (GO:0043403) | 4.06401611 |
| 76 | oxidative phosphorylation (GO:0006119) | 4.04278759 |
| 77 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.03014971 |
| 78 | regulation of cardiac muscle contraction (GO:0055117) | 4.02773016 |
| 79 | oxygen transport (GO:0015671) | 3.97843077 |
| 80 | striated muscle atrophy (GO:0014891) | 3.95624972 |
| 81 | skeletal muscle contraction (GO:0003009) | 3.95317675 |
| 82 | regulation of ATP catabolic process (GO:1903289) | 3.94857639 |
| 83 | regulation of ATPase activity (GO:0043462) | 3.94857639 |
| 84 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.94532428 |
| 85 | muscle hypertrophy in response to stress (GO:0003299) | 3.94532428 |
| 86 | cardiac muscle adaptation (GO:0014887) | 3.94532428 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.92888970 |
| 88 | regulation of sequestering of triglyceride (GO:0010889) | 3.89336586 |
| 89 | regulation of heart rate (GO:0002027) | 3.88129310 |
| 90 | negative regulation of protein localization to cell surface (GO:2000009) | 3.86384884 |
| 91 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.85914369 |
| 92 | polysaccharide catabolic process (GO:0000272) | 3.84913109 |
| 93 | negative regulation of potassium ion transport (GO:0043267) | 3.83341326 |
| 94 | muscle cell fate commitment (GO:0042693) | 3.81421045 |
| 95 | cardiac muscle cell action potential (GO:0086001) | 3.79912811 |
| 96 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.77076370 |
| 97 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.77076370 |
| 98 | regulation of heart contraction (GO:0008016) | 3.68344454 |
| 99 | carnitine transmembrane transport (GO:1902603) | 3.68252644 |
| 100 | muscle contraction (GO:0006936) | 3.67558007 |
| 101 | muscle adaptation (GO:0043500) | 3.67075329 |
| 102 | positive regulation of cation channel activity (GO:2001259) | 3.66082307 |
| 103 | striated muscle cell development (GO:0055002) | 3.64938817 |
| 104 | muscle organ development (GO:0007517) | 3.64224954 |
| 105 | muscle structure development (GO:0061061) | 3.62962850 |
| 106 | cell communication by electrical coupling (GO:0010644) | 3.59876468 |
| 107 | gluconeogenesis (GO:0006094) | 3.58570983 |
| 108 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.58380911 |
| 109 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.57833467 |
| 110 | response to inactivity (GO:0014854) | 3.57037089 |
| 111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.56579617 |
| 112 | relaxation of cardiac muscle (GO:0055119) | 3.56471134 |
| 113 | glycogen metabolic process (GO:0005977) | 3.55110717 |
| 114 | regulation of cardioblast differentiation (GO:0051890) | 3.54394890 |
| 115 | regulation of sulfur metabolic process (GO:0042762) | 3.53985056 |
| 116 | muscle atrophy (GO:0014889) | 3.53317793 |
| 117 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.52912873 |
| 118 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.52912873 |
| 119 | positive regulation of heart rate (GO:0010460) | 3.52379501 |
| 120 | response to activity (GO:0014823) | 3.50924954 |
| 121 | striated muscle adaptation (GO:0014888) | 3.48704020 |
| 122 | glucan metabolic process (GO:0044042) | 3.48014047 |
| 123 | cellular glucan metabolic process (GO:0006073) | 3.48014047 |
| 124 | fructose metabolic process (GO:0006000) | 3.47125558 |
| 125 | positive regulation of heart contraction (GO:0045823) | 3.44154925 |
| 126 | muscle system process (GO:0003012) | 3.43489268 |
| 127 | muscle organ morphogenesis (GO:0048644) | 3.38049439 |
| 128 | cardiac conduction (GO:0061337) | 3.37119316 |
| 129 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.36342803 |
| 130 | regulation of muscle contraction (GO:0006937) | 3.35331998 |
| 131 | myoblast fusion (GO:0007520) | 3.34758629 |
| 132 | amino-acid betaine transport (GO:0015838) | 3.34616184 |
| 133 | carnitine transport (GO:0015879) | 3.34616184 |
| 134 | regulation of muscle system process (GO:0090257) | 3.33966184 |
| 135 | muscle cell development (GO:0055001) | 3.33324956 |
| 136 | ventricular cardiac muscle cell development (GO:0055015) | 3.33045259 |
| 137 | regulation of myoblast differentiation (GO:0045661) | 3.24511899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.75974149 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.79114754 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.73658585 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.16484093 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.16484093 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.06633312 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.90863437 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.56912496 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.14669598 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.04713083 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.98979615 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.80268269 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.64663338 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46228299 |
| 15 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.31970378 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.22197135 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21154335 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.02696341 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.95948344 |
| 20 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.90676659 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88215054 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88025411 |
| 23 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.80114144 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68949943 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63891693 |
| 26 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.61632765 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58184527 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55531232 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55170346 |
| 30 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.50039682 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49221705 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48489711 |
| 33 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42304743 |
| 34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.38746100 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38722797 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.38639782 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36718875 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32732822 |
| 39 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.29679740 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28673175 |
| 41 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25912806 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.25675461 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24926006 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24058721 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20899796 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20314042 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18288629 |
| 48 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17547452 |
| 49 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.16941105 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16297279 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15579359 |
| 52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13106131 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12537933 |
| 54 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11581995 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10921649 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08599893 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08217269 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08191791 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06684882 |
| 60 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05678490 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04663221 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.04394471 |
| 63 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02775209 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01366295 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00231080 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99379664 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99346366 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97865585 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97301798 |
| 70 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.96886418 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96494125 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95677997 |
| 73 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94543417 |
| 74 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94081601 |
| 75 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93063107 |
| 76 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92820089 |
| 77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92347277 |
| 78 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89434559 |
| 79 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89303962 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88889175 |
| 81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88833407 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88802356 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88733494 |
| 84 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88088463 |
| 85 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87239866 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86138752 |
| 87 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85759485 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85397261 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85209422 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84971756 |
| 91 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84796504 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84458138 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84366012 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84323613 |
| 95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84230597 |
| 96 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84109250 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84057720 |
| 98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83591152 |
| 99 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83430777 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83192416 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83045702 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82846808 |
| 103 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.82460351 |
| 104 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.82316171 |
| 105 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81108190 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81068089 |
| 107 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.81004293 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80258496 |
| 109 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79929464 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79777971 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.79457400 |
| 112 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78020650 |
| 113 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.77686947 |
| 114 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77455454 |
| 115 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.77389600 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77208714 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76475823 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76274881 |
| 119 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.76053479 |
| 120 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.75902490 |
| 121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75277173 |
| 122 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.75106326 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74741669 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73523216 |
| 125 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73430013 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73020932 |
| 127 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72224760 |
| 128 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72187301 |
| 129 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71952905 |
| 130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.71221650 |
| 131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70680715 |
| 132 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.70503615 |
| 133 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.70075894 |
| 134 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.69781839 |
| 135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69410001 |
| 136 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.69123805 |
| 137 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.67962760 |
| 138 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.67962760 |
| 139 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.66733069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.30501729 |
| 2 | MP0003646_muscle_fatigue | 6.11241887 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.60772310 |
| 4 | MP0000751_myopathy | 5.27515001 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.60062847 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.34936026 |
| 7 | MP0000749_muscle_degeneration | 4.10928573 |
| 8 | MP0005330_cardiomyopathy | 3.86886761 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.11421939 |
| 10 | MP0002972_abnormal_cardiac_muscle | 3.10677123 |
| 11 | MP0003137_abnormal_impulse_conducting | 2.82664962 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.76027748 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.72021073 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.71003487 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.60052298 |
| 16 | MP0004130_abnormal_muscle_cell | 2.55068598 |
| 17 | MP0010630_abnormal_cardiac_muscle | 2.51384060 |
| 18 | * MP0001544_abnormal_cardiovascular_syste | 2.49360673 |
| 19 | * MP0005385_cardiovascular_system_phenoty | 2.49360673 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 2.44653367 |
| 21 | MP0004484_altered_response_of | 2.43730688 |
| 22 | MP0006138_congestive_heart_failure | 2.41383353 |
| 23 | MP0002269_muscular_atrophy | 2.40485909 |
| 24 | MP0003828_pulmonary_edema | 2.18648002 |
| 25 | MP0005369_muscle_phenotype | 2.12275033 |
| 26 | MP0000747_muscle_weakness | 2.09322579 |
| 27 | MP0000759_abnormal_skeletal_muscle | 2.09043386 |
| 28 | MP0004085_abnormal_heartbeat | 2.05085849 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.94375550 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.84114767 |
| 31 | MP0004233_abnormal_muscle_weight | 1.78010910 |
| 32 | MP0004510_myositis | 1.65014620 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.57781316 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.51506444 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.48317042 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.45993390 |
| 37 | MP0005670_abnormal_white_adipose | 1.37874906 |
| 38 | MP0004270_analgesia | 1.21563126 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.18500161 |
| 40 | MP0000343_altered_response_to | 1.18252122 |
| 41 | MP0000266_abnormal_heart_morphology | 1.09468057 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.08968766 |
| 43 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07705211 |
| 44 | MP0005165_increased_susceptibility_to | 1.04453906 |
| 45 | MP0003279_aneurysm | 1.03444071 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.02471768 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.02056722 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.00455549 |
| 49 | MP0002108_abnormal_muscle_morphology | 0.92064293 |
| 50 | MP0005266_abnormal_metabolism | 0.86585217 |
| 51 | MP0000230_abnormal_systemic_arterial | 0.83398361 |
| 52 | MP0002909_abnormal_adrenal_gland | 0.79400462 |
| 53 | MP0001661_extended_life_span | 0.78893644 |
| 54 | MP0004043_abnormal_pH_regulation | 0.78221198 |
| 55 | * MP0002128_abnormal_blood_circulation | 0.69842748 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 0.68774138 |
| 57 | MP0005623_abnormal_meninges_morphology | 0.66581280 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.63009803 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.61893421 |
| 60 | MP0003566_abnormal_cell_adhesion | 0.60944372 |
| 61 | MP0000733_abnormal_muscle_development | 0.59527303 |
| 62 | MP0000003_abnormal_adipose_tissue | 0.58691371 |
| 63 | MP0003045_fibrosis | 0.56998531 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 0.56838664 |
| 65 | MP0000767_abnormal_smooth_muscle | 0.55611849 |
| 66 | MP0004147_increased_porphyrin_level | 0.54878109 |
| 67 | MP0002971_abnormal_brown_adipose | 0.54636645 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.53170418 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.49988176 |
| 70 | MP0005451_abnormal_body_composition | 0.47550310 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.47441527 |
| 72 | MP0005187_abnormal_penis_morphology | 0.47369898 |
| 73 | MP0001299_abnormal_eye_distance/ | 0.45046706 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.43589692 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.41461666 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 0.39896187 |
| 77 | MP0003879_abnormal_hair_cell | 0.39294352 |
| 78 | MP0002925_abnormal_cardiovascular_devel | 0.38891673 |
| 79 | MP0005535_abnormal_body_temperature | 0.37613166 |
| 80 | MP0002822_catalepsy | 0.37227472 |
| 81 | MP0010030_abnormal_orbit_morphology | 0.36642419 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.35661402 |
| 83 | MP0009840_abnormal_foam_cell | 0.35507864 |
| 84 | MP0005275_abnormal_skin_tensile | 0.35030897 |
| 85 | MP0003195_calcinosis | 0.34716697 |
| 86 | MP0004134_abnormal_chest_morphology | 0.34526462 |
| 87 | MP0004272_abnormal_basement_membrane | 0.33135565 |
| 88 | MP0005083_abnormal_biliary_tract | 0.33023205 |
| 89 | MP0000762_abnormal_tongue_morphology | 0.31813989 |
| 90 | MP0005334_abnormal_fat_pad | 0.31328192 |
| 91 | MP0005166_decreased_susceptibility_to | 0.31246565 |
| 92 | MP0005332_abnormal_amino_acid | 0.31000919 |
| 93 | MP0003984_embryonic_growth_retardation | 0.30900304 |
| 94 | MP0003948_abnormal_gas_homeostasis | 0.30250297 |
| 95 | MP0001614_abnormal_blood_vessel | 0.30039250 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.29941728 |
| 97 | MP0001784_abnormal_fluid_regulation | 0.29622634 |
| 98 | MP0002088_abnormal_embryonic_growth/wei | 0.29443234 |
| 99 | MP0002896_abnormal_bone_mineralization | 0.29329285 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.29324705 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.28952272 |
| 102 | MP0004924_abnormal_behavior | 0.28952272 |
| 103 | MP0005452_abnormal_adipose_tissue | 0.27973182 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.27110183 |
| 105 | MP0005423_abnormal_somatic_nervous | 0.25721168 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.24796972 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.24095163 |
| 108 | MP0002114_abnormal_axial_skeleton | 0.24011477 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.23884994 |
| 110 | MP0004142_abnormal_muscle_tone | 0.23864598 |
| 111 | MP0001346_abnormal_lacrimal_gland | 0.23844038 |
| 112 | MP0000249_abnormal_blood_vessel | 0.23450951 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.22370687 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.22202986 |
| 115 | MP0009115_abnormal_fat_cell | 0.22081553 |
| 116 | MP0003011_delayed_dark_adaptation | 0.21745394 |
| 117 | MP0008569_lethality_at_weaning | 0.20589713 |
| 118 | MP0009672_abnormal_birth_weight | 0.19224553 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.18930009 |
| 120 | MP0001853_heart_inflammation | 0.18008461 |
| 121 | MP0002734_abnormal_mechanical_nocicepti | 0.17954660 |
| 122 | MP0008874_decreased_physiological_sensi | 0.17716930 |
| 123 | MP0001943_abnormal_respiration | 0.17505018 |
| 124 | MP0002066_abnormal_motor_capabilities/c | 0.17390149 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.16852552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.68863747 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.94831974 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.80303458 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.32592341 |
| 5 | Exercise-induced myalgia (HP:0003738) | 6.11040967 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.09445636 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.96677679 |
| 8 | Atrial fibrillation (HP:0005110) | 5.88103231 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 5.50323143 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 5.40443945 |
| 11 | Distal arthrogryposis (HP:0005684) | 5.37166790 |
| 12 | Supraventricular tachycardia (HP:0004755) | 5.32305643 |
| 13 | Myopathic facies (HP:0002058) | 5.30424573 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 5.25587481 |
| 15 | Lipoatrophy (HP:0100578) | 5.24322881 |
| 16 | Supraventricular arrhythmia (HP:0005115) | 5.20944485 |
| 17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.16102637 |
| 18 | Subaortic stenosis (HP:0001682) | 5.16102637 |
| 19 | Myoglobinuria (HP:0002913) | 4.81312170 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 4.67890800 |
| 21 | Bundle branch block (HP:0011710) | 4.67073145 |
| 22 | Round ear (HP:0100830) | 4.62989061 |
| 23 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.50312770 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 4.45624256 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 4.38571520 |
| 26 | Palpitations (HP:0001962) | 4.37715842 |
| 27 | Syncope (HP:0001279) | 4.37459222 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 4.30573929 |
| 29 | Ulnar deviation of the wrist (HP:0003049) | 4.29159539 |
| 30 | Prolonged QT interval (HP:0001657) | 4.10437587 |
| 31 | Increased connective tissue (HP:0009025) | 4.05805842 |
| 32 | Heart block (HP:0012722) | 3.80050728 |
| 33 | Difficulty running (HP:0009046) | 3.78181831 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.74491998 |
| 35 | Calcaneovalgus deformity (HP:0001848) | 3.74330648 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.66724998 |
| 37 | Abnormal atrioventricular conduction (HP:0005150) | 3.58960804 |
| 38 | Myotonia (HP:0002486) | 3.58460973 |
| 39 | Atrioventricular block (HP:0001678) | 3.54683903 |
| 40 | Acute necrotizing encephalopathy (HP:0006965) | 3.46030083 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.42901015 |
| 42 | Ventricular fibrillation (HP:0001663) | 3.39842107 |
| 43 | Deformed tarsal bones (HP:0008119) | 3.31361643 |
| 44 | Absent phalangeal crease (HP:0006109) | 3.30480087 |
| 45 | Frequent falls (HP:0002359) | 3.19787274 |
| 46 | Hepatic necrosis (HP:0002605) | 3.17172093 |
| 47 | Difficulty climbing stairs (HP:0003551) | 3.01468893 |
| 48 | Acute encephalopathy (HP:0006846) | 2.97959173 |
| 49 | Abnormal EKG (HP:0003115) | 2.97369684 |
| 50 | Left ventricular hypertrophy (HP:0001712) | 2.95254675 |
| 51 | Malignant hyperthermia (HP:0002047) | 2.90744445 |
| 52 | Progressive macrocephaly (HP:0004481) | 2.86514710 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.85034943 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.80581266 |
| 55 | Mitochondrial inheritance (HP:0001427) | 2.78669981 |
| 56 | Ketoacidosis (HP:0001993) | 2.76419690 |
| 57 | Abnormal finger flexion creases (HP:0006143) | 2.72657061 |
| 58 | Muscle fiber inclusion bodies (HP:0100299) | 2.68114910 |
| 59 | Areflexia of lower limbs (HP:0002522) | 2.67494094 |
| 60 | Type 1 muscle fiber predominance (HP:0003803) | 2.66883819 |
| 61 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.64969072 |
| 62 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64687063 |
| 63 | Cerebral edema (HP:0002181) | 2.63644025 |
| 64 | Muscle stiffness (HP:0003552) | 2.62762004 |
| 65 | Palmoplantar keratoderma (HP:0000982) | 2.60975965 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.57654810 |
| 67 | Testicular atrophy (HP:0000029) | 2.56448049 |
| 68 | Weak cry (HP:0001612) | 2.56080037 |
| 69 | Increased CSF lactate (HP:0002490) | 2.55371215 |
| 70 | Bulbar palsy (HP:0001283) | 2.54207425 |
| 71 | Hypoglycemic coma (HP:0001325) | 2.51983975 |
| 72 | Neck muscle weakness (HP:0000467) | 2.51665372 |
| 73 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.47758152 |
| 74 | Scapular winging (HP:0003691) | 2.45822571 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.45677763 |
| 76 | Progressive muscle weakness (HP:0003323) | 2.37124986 |
| 77 | Exercise intolerance (HP:0003546) | 2.34922693 |
| 78 | Conjunctival hamartoma (HP:0100780) | 2.30665502 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28859743 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 2.28859743 |
| 81 | Ragged-red muscle fibers (HP:0003200) | 2.27638002 |
| 82 | Respiratory failure (HP:0002878) | 2.26851694 |
| 83 | Fatigable weakness (HP:0003473) | 2.26781418 |
| 84 | Abnormality of the neuromuscular junction (HP:0003398) | 2.26781418 |
| 85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25474164 |
| 86 | Lactic acidosis (HP:0003128) | 2.20882896 |
| 87 | Fetal akinesia sequence (HP:0001989) | 2.19246452 |
| 88 | Pheochromocytoma (HP:0002666) | 2.17262736 |
| 89 | Slender build (HP:0001533) | 2.16853596 |
| 90 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15198547 |
| 91 | Rimmed vacuoles (HP:0003805) | 2.14836533 |
| 92 | Lower limb amyotrophy (HP:0007210) | 2.12457137 |
| 93 | Proximal amyotrophy (HP:0007126) | 2.11306711 |
| 94 | Abnormality of the calcaneus (HP:0008364) | 2.10836663 |
| 95 | Abnormality of the foot musculature (HP:0001436) | 2.09837411 |
| 96 | Hip contracture (HP:0003273) | 2.07930142 |
| 97 | Distal lower limb amyotrophy (HP:0008944) | 2.07746245 |
| 98 | Ketosis (HP:0001946) | 2.07232313 |
| 99 | Spinal rigidity (HP:0003306) | 2.04285077 |
| 100 | Muscular dystrophy (HP:0003560) | 2.03484181 |
| 101 | Large for gestational age (HP:0001520) | 2.02030157 |
| 102 | EMG: neuropathic changes (HP:0003445) | 2.01162538 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 2.01020798 |
| 104 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00149284 |
| 105 | Hyperkalemia (HP:0002153) | 1.99482684 |
| 106 | Gowers sign (HP:0003391) | 1.98150566 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97266093 |
| 108 | Waddling gait (HP:0002515) | 1.97083003 |
| 109 | Congestive heart failure (HP:0001635) | 1.96725337 |
| 110 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.95281585 |
| 111 | Neuroendocrine neoplasm (HP:0100634) | 1.95086861 |
| 112 | Neoplasm of head and neck (HP:0012288) | 1.94352128 |
| 113 | Esophageal neoplasm (HP:0100751) | 1.94352128 |
| 114 | Nemaline bodies (HP:0003798) | 1.94046411 |
| 115 | Sudden cardiac death (HP:0001645) | 1.94016101 |
| 116 | Hypoplastic ischia (HP:0003175) | 1.90711456 |
| 117 | Hamartoma of the eye (HP:0010568) | 1.89202259 |
| 118 | Dysmetric saccades (HP:0000641) | 1.87795202 |
| 119 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83428197 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 1.83428197 |
| 121 | Hyperalaninemia (HP:0003348) | 1.83428197 |
| 122 | Facial diplegia (HP:0001349) | 1.83102094 |
| 123 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82629740 |
| 124 | Generalized muscle weakness (HP:0003324) | 1.79496564 |
| 125 | Neoplasm of the adrenal gland (HP:0100631) | 1.75208538 |
| 126 | Tinnitus (HP:0000360) | 1.73821417 |
| 127 | Congenital malformation of the right heart (HP:0011723) | 1.72954735 |
| 128 | Double outlet right ventricle (HP:0001719) | 1.72954735 |
| 129 | Limb-girdle muscle weakness (HP:0003325) | 1.67161587 |
| 130 | Popliteal pterygium (HP:0009756) | 1.66131460 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 1.59286068 |
| 132 | Nonprogressive disorder (HP:0003680) | 1.55363955 |
| 133 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.54290042 |
| 134 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.54290042 |
| 135 | Metatarsus adductus (HP:0001840) | 1.53038044 |
| 136 | Muscle fiber atrophy (HP:0100295) | 1.49496662 |
| 137 | Steppage gait (HP:0003376) | 1.44964174 |
| 138 | Shoulder girdle muscle weakness (HP:0003547) | 1.43374869 |
| 139 | Pelvic girdle muscle weakness (HP:0003749) | 1.42760737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.63182574 |
| 2 | PHKG2 | 4.29025739 |
| 3 | PHKG1 | 4.29025739 |
| 4 | OBSCN | 4.12399324 |
| 5 | MYLK | 3.90779582 |
| 6 | LMTK2 | 3.85604475 |
| 7 | PDK4 | 3.30331206 |
| 8 | PDK3 | 3.30331206 |
| 9 | DMPK | 2.98749238 |
| 10 | BCKDK | 2.70303879 |
| 11 | PKN2 | 2.58637920 |
| 12 | MUSK | 2.55425496 |
| 13 | TRIB3 | 2.51147063 |
| 14 | PIK3CA | 2.31969927 |
| 15 | PINK1 | 2.18437726 |
| 16 | NEK1 | 2.16969716 |
| 17 | PDK2 | 1.97293624 |
| 18 | TIE1 | 1.90877792 |
| 19 | STK24 | 1.58448805 |
| 20 | PAK3 | 1.53608074 |
| 21 | GRK7 | 1.46117783 |
| 22 | PRKD1 | 1.34434587 |
| 23 | CAMK2D | 1.26325719 |
| 24 | CDC42BPA | 1.23062769 |
| 25 | LIMK1 | 1.06794179 |
| 26 | MARK1 | 1.06750784 |
| 27 | MAPK12 | 1.05322834 |
| 28 | MAP3K7 | 1.04565218 |
| 29 | ILK | 1.02776399 |
| 30 | ROCK1 | 1.02158811 |
| 31 | MAPKAPK3 | 0.99946697 |
| 32 | STK4 | 0.99892009 |
| 33 | PKN1 | 0.97984452 |
| 34 | WNK4 | 0.97688855 |
| 35 | MOS | 0.95217118 |
| 36 | CCNB1 | 0.94307376 |
| 37 | DAPK3 | 0.93445206 |
| 38 | MAP2K3 | 0.93438537 |
| 39 | INSRR | 0.90348884 |
| 40 | PRKAA1 | 0.88949529 |
| 41 | MAP3K5 | 0.87167496 |
| 42 | EEF2K | 0.86304269 |
| 43 | NME1 | 0.84995255 |
| 44 | RIPK1 | 0.84742255 |
| 45 | STK38L | 0.83088220 |
| 46 | FLT3 | 0.82744464 |
| 47 | PRKAA2 | 0.80734998 |
| 48 | ZAK | 0.78905816 |
| 49 | TRPM7 | 0.74612019 |
| 50 | PDGFRA | 0.73280650 |
| 51 | CAMK4 | 0.70785460 |
| 52 | DYRK1B | 0.67270355 |
| 53 | RPS6KC1 | 0.66629099 |
| 54 | RPS6KL1 | 0.66629099 |
| 55 | MAP3K3 | 0.64840472 |
| 56 | STK38 | 0.64099774 |
| 57 | ERBB3 | 0.63851166 |
| 58 | ROCK2 | 0.63793158 |
| 59 | CAMK2A | 0.59147284 |
| 60 | EPHB1 | 0.58818506 |
| 61 | RPS6KA6 | 0.57936798 |
| 62 | NME2 | 0.56405921 |
| 63 | WNK1 | 0.55974564 |
| 64 | TGFBR2 | 0.55068850 |
| 65 | MAPK4 | 0.54072616 |
| 66 | PRKACB | 0.52590780 |
| 67 | MAP2K1 | 0.52086426 |
| 68 | KDR | 0.51365391 |
| 69 | MAP3K13 | 0.50105327 |
| 70 | CAMK2B | 0.49502719 |
| 71 | PRKCE | 0.47004474 |
| 72 | CAMK1 | 0.45262085 |
| 73 | PTK2B | 0.43590452 |
| 74 | PRKACA | 0.41531843 |
| 75 | PRKD3 | 0.39772541 |
| 76 | PRKACG | 0.39027476 |
| 77 | NEK9 | 0.38317074 |
| 78 | PDPK1 | 0.37764111 |
| 79 | CAMK2G | 0.37659099 |
| 80 | KSR2 | 0.36064799 |
| 81 | ICK | 0.35596730 |
| 82 | AKT2 | 0.35508592 |
| 83 | PRKCH | 0.34854076 |
| 84 | MAPKAPK5 | 0.31760830 |
| 85 | PIK3CG | 0.31075226 |
| 86 | MAP3K6 | 0.28762869 |
| 87 | SIK1 | 0.28402583 |
| 88 | PTK6 | 0.28199849 |
| 89 | PDK1 | 0.27909437 |
| 90 | TBK1 | 0.27711756 |
| 91 | RPS6KA1 | 0.26916651 |
| 92 | STK39 | 0.25444562 |
| 93 | SGK2 | 0.23884255 |
| 94 | TAOK2 | 0.23273470 |
| 95 | FER | 0.20974560 |
| 96 | PRKG2 | 0.20963291 |
| 97 | MAP2K4 | 0.20887705 |
| 98 | MAPK10 | 0.20727317 |
| 99 | EPHB2 | 0.20427633 |
| 100 | SGK3 | 0.20110984 |
| 101 | JAK1 | 0.20011801 |
| 102 | PRKG1 | 0.19814671 |
| 103 | ARAF | 0.19180738 |
| 104 | MAP3K1 | 0.19023327 |
| 105 | MTOR | 0.19006191 |
| 106 | RPS6KA2 | 0.18699188 |
| 107 | MARK2 | 0.18697220 |
| 108 | SGK1 | 0.17849959 |
| 109 | PRPF4B | 0.17621434 |
| 110 | TAOK1 | 0.17399898 |
| 111 | RPS6KA3 | 0.16404173 |
| 112 | CDK8 | 0.15873727 |
| 113 | MAPK11 | 0.15773012 |
| 114 | RPS6KB1 | 0.15495938 |
| 115 | MAP2K6 | 0.15229182 |
| 116 | ZAP70 | 0.14119907 |
| 117 | LATS2 | 0.13617325 |
| 118 | RPS6KB2 | 0.13598304 |
| 119 | RET | 0.11308024 |
| 120 | MAPK7 | 0.10738676 |
| 121 | FGFR4 | 0.10729244 |
| 122 | EPHA3 | 0.10297133 |
| 123 | DAPK2 | 0.09746795 |
| 124 | MAPK13 | 0.09683333 |
| 125 | MAPKAPK2 | 0.09611501 |
| 126 | MARK3 | 0.09132949 |
| 127 | MAP3K11 | 0.09066440 |
| 128 | MAP3K4 | 0.08181335 |
| 129 | SGK494 | 0.06627378 |
| 130 | SGK223 | 0.06627378 |
| 131 | PAK6 | 0.06619999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.80616400 |
| 2 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.32483956 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.18657609 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.75362352 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.67634068 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.55035356 |
| 7 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.54507711 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46615591 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22015403 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67310261 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.64781516 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.41577429 |
| 13 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.41550213 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.37546277 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24909957 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 2.21922990 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01321497 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82336423 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81139664 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71582197 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48510064 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41435762 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22417404 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21054129 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14636492 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07343279 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05922326 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.05142326 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.03461711 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02402923 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95683423 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95280332 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92413616 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88345712 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81021768 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75772943 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74853287 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74123732 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73059354 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72115331 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71745894 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 0.69980890 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67648061 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66249310 |
| 45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64704723 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64481841 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 0.62527029 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62079456 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61921376 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61228988 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58190775 |
| 52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57551211 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56046342 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.52294239 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.48759423 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47582537 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46403411 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45389486 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.44626477 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43032716 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42051379 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41769208 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41123012 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.39391432 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38755428 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38139433 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37127492 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35837787 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35148203 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34011552 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.33529570 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32319355 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.31947218 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29723023 |
| 75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.28948913 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27628623 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27577195 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.25578488 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.24626540 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.21731642 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.20492793 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20491425 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.20240393 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20052304 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18426095 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.16395085 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15928995 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.15430735 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15159622 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.14020190 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11934806 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11408866 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10817600 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10562649 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.10266232 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10027837 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.09843723 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09757779 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.09622306 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.09309636 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.07686837 |
| 102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07298194 |
| 103 | Taste transduction_Homo sapiens_hsa04742 | 0.07232408 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06304660 |
| 105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.06032034 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.05669434 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.04918932 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.02569053 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02419619 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.02372210 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.02113527 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0182732 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0116625 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0095860 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0082128 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0076020 |

